Kendall Capital Management - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Kendall Capital Management ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$252
+1.2%
2,4700.0%0.11%
+2.8%
Q2 2023$249
-2.4%
2,470
-10.8%
0.11%
-11.4%
Q1 2023$2550.0%2,770
-1.6%
0.12%
-4.7%
Q4 2022$255
-99.9%
2,816
-10.3%
0.13%
-7.2%
Q3 2022$239,000
-14.0%
3,141
-4.6%
0.14%
-9.2%
Q2 2022$278,000
-7.3%
3,293
-3.7%
0.15%
+5.5%
Q1 2022$300,000
+0.3%
3,4180.0%0.14%
+2.1%
Q4 2021$299,000
+6.8%
3,418
-0.3%
0.14%
-6.0%
Q3 2021$280,000
-10.3%
3,427
+0.3%
0.15%
-13.7%
Q2 2021$312,000
+3.7%
3,418
-2.8%
0.18%
-5.9%
Q1 2021$301,000
-9.3%
3,5180.0%0.19%
-23.1%
Q4 2020$332,000
+13.7%
3,518
+4.8%
0.24%
-4.7%
Q3 2020$292,000
-16.1%
3,358
-15.7%
0.25%
-23.7%
Q2 2020$348,000
+6.4%
3,983
+0.4%
0.33%
-10.0%
Q1 2020$327,000
-13.7%
3,968
-0.9%
0.37%
+24.2%
Q4 2019$379,000
+6.8%
4,005
-1.8%
0.30%
-5.1%
Q3 2019$355,000
-5.8%
4,080
-1.2%
0.31%
-7.9%
Q2 2019$377,000
-8.9%
4,130
-4.2%
0.34%
-13.0%
Q1 2019$414,000
+8.1%
4,310
-3.4%
0.39%
-1.3%
Q4 2018$383,000
-6.6%
4,460
-6.3%
0.40%
+13.8%
Q3 2018$410,000
-25.2%
4,760
-34.4%
0.35%
-27.9%
Q2 2018$548,000
-8.8%
7,260
-2.4%
0.48%
-7.1%
Q1 2018$601,000
+25.7%
7,435
+30.7%
0.52%
+22.9%
Q4 2017$478,0005,6900.42%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders